Novo Nordisk A/S (NONOF)
38.93
+0.03
(+0.07%)
USD |
OTCM |
Oct 26, 16:00
Novo Nordisk Market Cap : 172.09B for Oct. 26, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 172.09B |
| October 23, 2026 | 171.97B |
| October 22, 2026 | 174.34B |
| October 21, 2026 | 171.97B |
| October 20, 2026 | 172.26B |
| October 19, 2026 | 169.07B |
| October 16, 2026 | 171.70B |
| October 15, 2026 | 174.51B |
| October 14, 2026 | 166.62B |
| October 13, 2026 | 167.78B |
| October 12, 2026 | 171.48B |
| October 09, 2026 | 168.65B |
| October 08, 2026 | 169.23B |
| October 07, 2026 | 167.07B |
| October 06, 2026 | 165.31B |
| October 05, 2026 | 165.06B |
| October 02, 2026 | 163.61B |
| October 01, 2026 | 165.24B |
| September 30, 2026 | 168.65B |
| September 29, 2026 | 169.51B |
| September 28, 2026 | 169.66B |
| September 25, 2026 | 170.89B |
| September 24, 2026 | 169.76B |
| September 23, 2026 | 169.09B |
| September 22, 2026 | 173.82B |
| Date | Value |
|---|---|
| September 21, 2026 | 176.48B |
| September 18, 2026 | 188.40B |
| September 17, 2026 | 185.65B |
| September 16, 2026 | 183.72B |
| September 15, 2026 | 187.51B |
| September 14, 2026 | 193.04B |
| September 11, 2026 | 190.93B |
| September 10, 2026 | 195.15B |
| September 09, 2026 | 196.59B |
| September 08, 2026 | 200.89B |
| September 04, 2026 | 204.71B |
| September 03, 2026 | 205.56B |
| September 02, 2026 | 207.11B |
| September 01, 2026 | 200.48B |
| August 31, 2026 | 200.03B |
| August 28, 2026 | 199.01B |
| August 27, 2026 | 204.04B |
| August 26, 2026 | 209.50B |
| August 25, 2026 | 212.75B |
| August 24, 2026 | 207.78B |
| August 21, 2026 | 206.94B |
| August 20, 2026 | 204.81B |
| August 19, 2026 | 200.71B |
| August 18, 2026 | 198.57B |
| August 17, 2026 | 199.42B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.212T |
| ALK-Abello A/S | 8.099B |
| H. Lundbeck A/S | 6.796B |
| AstraZeneca PLC | 529.49B |
| GSK Plc | 103.38B |
Market Cap Related Metrics
| PE Ratio | 9.514 |
| PS Ratio | 3.363 |
| PEG Ratio | 0.755 |
| Price to Book Value | 5.085 |
| Price to Free Cash Flow | 23.48 |
| Price | 38.93 |
| Earnings Yield | 10.51% |
| PEGY Ratio | 0.5523 |
| Operating PE Ratio | 7.412 |
| Normalized PE Ratio | 9.145 |